It's also a tit-for-tat reply to Adam Feuerstein http://www.thestreet.com/story/10679292/1/cel-sci-cancer-drug-claims-crumble-part-1.html http://www.thestreet.com/story/10679302/1/cel-sci-cancer-drug-claims-crumble-part-ii.html